| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
NCE Biomedical Co.,Ltd. |
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Email: |
|
| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
|
| | MB-07133 Basic information |
| Product Name: | MB-07133 | | Synonyms: | MB-07133;MB-7133;4-Amino-1-[5-O-[(2R,4S)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl]-beta-D-arabinofuranosyl]-2(1H)-pyrimidinone;2(1H)-Pyrimidinone, 4-amino-1-[5-O-[(2R,4S)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl]-β-D-arabinofuranosyl]-;MB7133,MB 7133 | | CAS: | 685111-92-6 | | MF: | C17H21N4O8P | | MW: | 440.35 | | EINECS: | | | Product Categories: | | | Mol File: | 685111-92-6.mol |  |
| | MB-07133 Chemical Properties |
| Boiling point | 685.3±65.0 °C(Predicted) | | density | 1.80±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 13.36±0.70(Predicted) |
| | MB-07133 Usage And Synthesis |
| Uses | MB-7133 is a DNA synthesis inhibitor. | | References | [1] van Poelje PD,et al. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes. Handb Exp Pharmacol. 2011;(203):279-301. DOI:10.2174/138161207782360663 |
| | MB-07133 Preparation Products And Raw materials |
|